Literature DB >> 29115237

Extending survival for people with hepatitis C using tobacco dependence treatment.

Coral Gartner1, Alleshia Miller2, Billie Bonevski3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29115237     DOI： 10.1016/S0140-6736(17)32460-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).

Authors:  Tangui Barré; Patrick Mercié; Fabienne Marcellin; Laure Esterle; Claudine Duvivier; Elina Teicher; Morgane Bureau; Julie Chas; Dominique Salmon-Céron; Philippe Sogni; Maria Patrizia Carrieri; Linda Wittkop; Camelia Protopopescu
Journal:  AIDS Behav       Date:  2021-04-27

2.  Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial.

Authors:  Irene Pericot-Valverde; Moonseong Heo; Matthew J Akiyama; Brianna L Norton; Linda Agyemang; Jiajing Niu; Alain H Litwin
Journal:  BMC Infect Dis       Date:  2020-12-04       Impact factor: 3.090

3.  A descriptive analysis of concurrent alcohol and substance use among patients living with HIV/HCV co-infection.

Authors:  Omar T Sims; Kaiying Wang; Rasheeta Chandler; Pamela A Melton; Duong N Truong
Journal:  Soc Work Health Care       Date:  2020-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.